tert-Butyl (1R,2S)-2-aminocyclohexylcarbamate

Catalog No.: 
ACKZYS107
CAS No.: 
364385-54-6
Molecular Formula: 
C11H22N2O2
Molecular Weight: 
214.31
tert-Butyl (1R,2S)-2-aminocyclohexylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$123.00In stockInquiry
25g98%$460.00In stockInquiry
100g98%$1462.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1R,2S)-2-aminocyclohexylcarbamate
IUPAC Nametert-butyl ((1R,2S)-2-aminocyclohexyl)carbamate
MDL No.MFCD09952106
Molecular FormulaC11H22N2O2
Molecular Weight214.31
SMILESO=C(OC(C)(C)C)N[C@H]1[C@@H](N)CCCC1
InChI KeyAKVIZYGPJIWKOS-DTWKUNHWSA-N
SynonymCS-0137432 | SCHEMBL555256 | cis-N1-Boc-1,2-cyclohexanediamine | (1R,2S)-N1-Boc-1,2-cyclohexanediamine | AKVIZYGPJIWKOS-DTWKUNHWSA-N | tert-butyl (1R,2S)-2-aminocyclohexylcarbamate | N-Boc-1(R),2(S)-diaminocyclohexane, AldrichCPR | rac-tert-butyl N-[(1R,2
CAS No.364385-54-6
PubChem CID1514392

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACKZYS107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKZYS107 route product structure diagram
    ACKZYS107364385-54-6In Stock
Inquiry

2. ACKZYS107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKZYS107 route product structure diagram
    ACKZYS107364385-54-6In Stock
Inquiry

3. ACKZYS107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKZYS107 route product structure diagram
    ACKZYS107364385-54-6In Stock
Inquiry

Comments (0)